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INTRODUCTION
Rhodococcus equi infection is commonly encountered
in HIV-infected patients; recipients of organ transplants;
and in those with lymphoma, chronic renal failure, alco-
holism, lung cancer, leukaemia, diabetes mellitus, and other
states of immunodeficiency. Recent reports have also docu-
mented R. equi infections among immunocompetent pa-
tients.1 The most common manifestations of R. equi infec-
tions are multiple abscesses in the lungs, and extra-
pulmonary infections may include wound infections, sub-
cutaneous abscesses, brain abscesses, meningitis, peri-
carditis, osteomyelitis, cervical adenopathy, endo-
phthalmitis, lymphangitis, or mastoiditis.2 We report 2 cases
of lung abscesses with R. equi misdiagnosed as Coryne-
bacterium species.
CASE REPORT
Case 1
A 32-year-old man was admitted to the hospital in Sep-
tember of 2005 with 2 days of fever and 6 weeks of weight
loss and anorexia. He had a history of Hodgkin lymphoma
in 1992 and a secondary non-Hodgkin lymphoma in 2000,
with pulmonary Nocardia diagnosed together with the re-
lapse of lymphoma in 2002. He had undergone successful
autologous bone marrow transplantation in April of 2004.
His physical examination was within normal limits, but Co-
rynebacterium sp grew in 3 separate blood cultures. He was
observed for 2 days, and the clinician considered the iso-
lated bacteria to be a contaminant. He was discharged to
home 5 days after admission when he became afebrile and
had a normal examination, including thorax computed to-
mography. After 1 month, he was readmitted to the hospi-
tal with right side hemiparesis, nonproductive cough, and
fever again. A new chest computed tomography demon-
strated multiple nodular infiltrates in both lungs with 2 cavi-
ties (Figure 1). A brain magnetic resonance revealed a left
temporal nodular lesion with oedema. The patient had to
be admitted to the intensive care unit within 24 hours of
admission because of a progressive decrease in the level
of consciousness; then, dexametasone 24 mg was initiated.
Blood cultures were collected, and vancomycin 2000 mg
every day was initiated due to prior isolation of Coryne-
bacterium from the blood 1 month previously; ceftriaxone
(2000 mg every day) and trimethoprim/sulfamethoxazole
(20 mg/kg/day of sulfamethoxazole) were added because
of past nocardiosis; rifampin 600 mg, isoniazid 400 mg,
and pyrazinamide 2000 mg were added to cover for the pos-
sibility of Mycobacterium tuberculosis infection. Addition-
ally, the patient had hyponatremia and hyperkalemia, and
acute adrenal insufficiency was diagnosed by a cosyntropin
test.
The results of cultures from bronchoalveolar lavage were
negative. The bacteria from the first blood cultures were later
identified as Rhodococcus equi. A transesophageal
echocardiogram was negative for endocarditis and showed
cardiomyopathy with an ejection fraction of 31%. An HIV
screening test was negative. Urinalysis was normal. The
blood cultures before starting vancomycin were positive for
R. equi, and after 3 weeks of antibiotic, 2 new blood cul-
tures were still positive. His treatment continued with van-
comycin, rifampin, and trimethoprim/sulfamethoxazole, but
blood cultures were positive for R. equi 6 weeks after ad-
mission; the tuberculostatic medications and ceftriaxone
were discontinued. Vancomycin serum levels were deter-
mined, and the peak and basal levels, 32 µg/mL and 17 µg/
mL, respectively, were acceptable. An E-test (Progressive
Diagnostics Manufacturers epsilometer test; AB Biodisk,
Solna, Sweden) of susceptibility to vancomycin was per-
formed with a result of 1 µg/mL. A stereotactic biopsy of
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the brain lesion was inconclusive showing only necrotic ma-
terial and negative cultures. The patient died after 7 weeks
of therapy due to acute respiratory distress and refractory
shock.
Case 2
A 39-year-old woman was admitted in January 2001
with a 2-month history of productive cough, night fever,
anorexia, and weight loss. Fine crackles were presented in
the right lung, and a discrete hepatomegaly found. An x-
ray showed a cavity in the right lung, which was confirmed
by a thorax CT (Figure 2). A HIV test was positive, and
the CD4+ T lymphocyte count was 1 cell/mm3. Corynebac-
terium sp grew in 5 separate blood cultures collected at ad-
mission and subsequently in bone marrow and
bronchoalveolar lavage cultures. The bacteria from the
blood, bone marrow, and bronchoalveolar lavage cultures
were later identified as R. equi, and intravenous imipenem
2000 mg every day associated with oral rifampin 1200 mg
every day was initiated. Blood cultures were negative af-
ter 8 days of antibiotic therapy. A right lung pneumectomy
was performed after 40 days due to absence of radiologi-
cal improvement and maintenance of a low-grade fever and
productive cough. A pleural fistula was diagnosed 21 days
postsurgery, and the patient died 3 days later with septic
shock. A necropsy was performed, and sections of the in-
flated and formalin-fixed right lung revealed a yellow solid
and irregular mass in the middle lobe. Histologically, the
mass was represented by sheets of macrophages with foamy
or abundant granular eosinophilic cytoplasm that contained
Michaelis-Gutmann bodies, characterized by visible PAS-
positive and diastase-resistant basophilic structures with
targetoid-like concentric laminations. Gram-stained sections
were negative for bacteria, as were stains for fungi and acid-
fast organisms.
DISCUSSION
Rhodococcus equi is a bacterium identified in a vari-
ety of soils, water, and animals, including horses, cattle,
swine, and wild birds.3 Rhodococcus equi infection is rare,
but the incidence has increased markedly, which is coinci-
dent with the pandemia of AIDS, organ transplantation, and
Figure 1 - Thorax CT-scan showing a lung abscess in a patient with Rhodococcus equi bacteremia (B). The normal CT-scan 1 month before symptoms (A).
Magnetic resonance with a brain abscess (C).
Figure 2 - Thorax CT-scan (A) and Rx-ray (B) of Rhodococcus equi bacteremia with lung abscess. Lung histological section with sheets of macrophages
with foamy or abundant granular eosinophilic cytoplasm that contain Michaelis-Gutmann bodies, characterized by visible PAS-positive and diastase-
resistant basophilic structures with targetoid-like concentric laminations (C), (HE 400x).
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cancer treatment. Improvements in laboratory techniques
and recognition of gram-positive bacilli as pathogens also
explain the increase in the incidence of reports of R. equi
infection.3 More than 100 cases of human Rhodococci in-
fections have been published since 1967,4 when the first
R. equi infection in a human was reported.5 Rhodococci
belong to the family Nocardiaceae, which includes Coryne-
bacterium, Mycobacterium, Nocardia, and Gordonia spe-
cies. It is a nonmotile, gram-positive, obligate aerobe ca-
pable of metabolizing a wide variety of organic compounds.
On the basis of its morphologic characteristics, R. equi can
easily be mistaken for a diphtheroid contaminant, such as
Corynebacterium or Micrococcus organisms. On the basis
of acid-fast staining results, it can be mistaken for Myco-
bacterium organisms.6 Automated microbiologic identifi-
cation systems do not differentiate well between Coryne-
bacterium and R. equi, and this also may cause
misdiagnosis. In our cases, “Corynebacterium” was iden-
tified in an automatic hemoculture system from 3 separate
samples in 1 patient and in 5 samples in another. The cli-
nician should be cautious before considering this agent to
be a contaminant, particularly when the same agent is iso-
lated from separate samples. Communication between the
primary clinician who suspects R. equi infection and the
laboratory could ensure accurate diagnosis and improve
survival due to early treatment, avoiding secondary ab-
scess.6
The patient in case 1 was treated with vancomycin and
rifampin for 6 weeks, but bacteremia persisted. R. equi is
susceptible to vancomycin and rifampicin, although some
reports have demonstrated an increase in rifampin resist-
ance associated with the rpoB gene.7 Although adequate
serum levels of vancomycin were detected, it should be
noted that some studies have shown that the vancomycin
does not reach an adequate concentration in the lung when
serum levels are judged to be adequate. The antibiotic
therapy in case 1 consisted of generic vancomycin. Conti
Jr demonstrated in 1987 that both drugs had laboratory
equivalence; however, this has not been clinically verified.8
Although there is no standard antibiogram for R. equi by
CLSI (Clinical Laboratory Standards Institute), an E-test
with 3 consecutive measures was performed to rule out the
possibility of vancomycin resistance.9 The probability of
endocarditis was low because there was no evidence of veg-
etation in the transesophageal echocardiogram. Abscesses
could maintain a continuous status of bacteremia, but there
was no improvement in the clinical condition, and death
was the outcome. In numerous situations, including cases
of cerebral abscess, successful treatment starts with surgi-
cal resection, which is a consensus approach for Nocardia
abscess.10-12 Another concern would be the capacity of pen-
etration of vancomycin into abscesses. A previous study
measured the concentration of vancomycin in a cerebral
abscess, and the levels were similar to those of serum.13
This is virtually the first case of persistent R. equi
bacteremia described. The possibility of resistance could
be discharged, but the importance of standardization of sus-
ceptibility tests must be emphasized. A continuous main-
tenance of bacteremia due to lung and cerebral abscess
would be the only explanation for this case.
In the case 2, the bacteremia was successfully treated
with imipenem and rifampin, but the patient died due to
nosocomial infection after the surgical treatment of the ab-
scess. Malacoplakia was related to R. equi infection in pre-
vious report. It is an unusual inflammatory condition char-
acterized by the accumulation of macrophages with diag-
nostic Michaelis-Gutmann bodies.14 Although the
pathogenesis of malacoplakia is unknown, it is thought to
be an acquired disease secondary to immunosuppression
and a possible defect in the oxygen-independent microbi-
cidal system of macrophages.15
Infection caused by R. equi is a severe illness, given
that more than one third of the patients die due to causes
attributable to the infection,16 with an overall mortality of
nearly 60%.1 A standard antibiogram method is necessary
due the increase in resistance of gram-positive organisms.
Surgical drainage of a R. equi abscess must be considered,
and prospective studies analyzing the ideal approach should
be done. Correct diagnosis and reporting of these cases are
important for understanding of and increasing the experi-
ence with this rare infectious agent.
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